FGF2 and oral cavity squamous cell carcinoma: Previous study indicated that ED-71 could suppress oral squamous cell carcinoma by inhibiting HBp17/FGFBP-1, FGF-2, CD31, Ki-67, and Cyp24A1 [27,28].